De novo donor specific antibodies and patient outcomes in renal transplantation.

Clinical transplants

Volumn , Issue , 2011, Pages 351-358

  DeVos, J M ^a   Patel, S J ^b   Burns, K M ^b   Dilioglou, S ^b   Gaber, L W ^b   Knight, R J ^b   Gaber, A O ^b   Land, G A ^b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BIOLOGICAL MARKER; CREATININE; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BIOPSY; BLOOD; CHI SQUARE DISTRIBUTION; DRUG EFFECT; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGICAL MONITORING; IMMUNOLOGY; KAPLAN MEIER METHOD; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; RETROSPECTIVE STUDY; TIME; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME; UNITED STATES;

ADULT; BIOLOGICAL MARKERS; BIOPSY; CHI-SQUARE DISTRIBUTION; CREATININE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MONITORING, IMMUNOLOGIC; PANCREAS TRANSPLANTATION; RETROSPECTIVE STUDIES; TEXAS; TIME FACTORS; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

EID: 84864086096     PISSN: 08909016     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)